Besides, elevated HIF-1α expression correlates with poor prognosis and cytarabine resistance in NPM1-mutated/FLT3-ITD-negative AML subtypes, establishing it as a predictive biomarker (133). The gene discussed is FLT3; the disease is acute myeloid leukemia.